首页> 外文期刊>Antiviral Research >Adenovirus-mediated shRNA interference against porcine circovirus type 2 replication both in vitro and in vivo.
【24h】

Adenovirus-mediated shRNA interference against porcine circovirus type 2 replication both in vitro and in vivo.

机译:在体外和体内,腺病毒介导的shRNA干扰猪圆环病毒2型复制。

获取原文
获取原文并翻译 | 示例
       

摘要

Porcine circovirus type 2 (PCV2) is the primary causative agent of an emerging swine disease, postweaning multisystemic wasting syndrome (PMWS), which is responsible for the heavy economic losses in stockbreeding. There are no specific antiviral drugs for treatment of the virus infection. We have now constructed two recombinant adenoviruses expressing short-hairpin RNAs (shRNAs) directed against either ORF1 (rAdS1) or ORF2 (rAdS2) of PCV2 and measured the inhibition of PCV2 replication. The results showed that delivery of these shRNAs by recombinant adenovirus into PK15 cells could induce a significant inhibition of viral RNA and DNA replication and protein synthesis level in cells subsequently infected with PCV2. The antiviral effect was dose-dependent and could sustain at least for 120h and the inhibition of virus replication could be significantly strengthened by combination of rAdS1 with rAdS2. Mice injected with shRNA before PCV2 infection showed substantial and low level of PCV2 DNA replication in the spleen during the period of 21-28 days post-PCV2 infection. These results indicated that shRNAs generated by adenovirus could sufficiently and continuously inhibit PCV2 infection in vitro as well as in vivo. The adenovirus based shRNA targeting ORF1 and ORF2 of PCV2 might be a new potential alternative strategy for controlling PCV2 infection.
机译:猪圆环病毒2型(PCV2)是断奶后多系统消耗综合症(PMWS)引起的新型猪病的主要病原体,造成了繁重的经济养殖损失。没有用于治疗病毒感染的特定抗病毒药物。现在,我们已经构建了两种表达针对PCV2的ORF1(rAdS1)或ORF2(rAdS2)的短发夹RNA(shRNA)的重组腺病毒,并测量了PCV2复制的抑制作用。结果表明,重组腺病毒将这些shRNA传递至PK15细胞后,可显着抑制随后感染PCV2的细胞中病毒RNA和DNA复制以及蛋白质合成水平。 rAdS1和rAdS2的组合可显着增强抗病毒作用,且剂量依赖性且可持续至少120h。在PCV2感染后的21-28天期间,在PCV2感染前注射shRNA的小鼠的脾脏中PCV2 DNA复制水平显着降低。这些结果表明,由腺病毒产生的shRNA可以在体内外充分,连续地抑制PCV2感染。靶向PCV2 ORF1和ORF2的基于腺病毒的shRNA可能是控制PCV2感染的新的潜在替代策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号